# Ingenio Device Algorithm Study

Study · id `cardio:ct-nct01441583` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01441583](<https://clinicaltrials.gov/study/NCT01441583>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01441583

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.

## Technical summary

Registry record NCT01441583. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2012-06 (actual). Results posted on 2024-03-21.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 139 participants (enrolled count; ClinicalTrials.gov record NCT01441583, source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01441583, source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)
- Primary completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01441583, source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)
- Completion: 2013-04 (actual) (ClinicalTrials.gov record NCT01441583, source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)
- Results first posted: 2024-03-21 (ClinicalTrials.gov record NCT01441583, source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)
- Countries: Austria; Belgium; Denmark; France; Germany; Hong Kong SAR China; Italy; Malaysia; Netherlands; Spain; Sweden; United Kingdom (ClinicalTrials.gov record NCT01441583, source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01441583-2024-03-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ingenio Device Algorithm Study
- Acronym: IVORY
- Condition: Sinus Node Disease
- Condition: AV Block
- Condition: Heart Failure
- Intervention (Device): RAAT
- Intervention (Device): RYTHMIQ
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Sick sinus syndrome (`cardio:sick-sinus-syndrome`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: f3d3ed5ec864d58fbe52c9f8e366a6ec3c1cfe953fa2b5e38426e3d4bd6d9a42
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
